Gorilla Technology Group Signs Heads of Terms to Acquire Bacom Internetwork

–Bolsters global expansion strategy– –Entry point to provide Smart City solutions in Thailand– LONDON, June 12, 2023 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and cybersecurity, today announced that it agreed to binding terms to acquire Bacom Internetwork, a leading pioneer, distributor […]

Read More »

First Cryptocurrency Miners with Plug-and-Play Integrated

NEW YORK, June 12, 2023 (GLOBE NEWSWIRE) — The crypto market has recently witnessed the emergence of the world’s first plug-and-play crypto miners that can be used without any prior mining knowledge or experience. Bitmanu’s BM1, BM2, and BM Pro miners allow users to start mining simply by connecting to the internet via Wi-Fi or Cable […]

Read More »

Legality and Merit Prize, projects awarded in Rome’s Luiss University by the Italian Ministers

Paola Severino Stimulating dialogue between the university and high school students, combating educational poverty, and promoting the transmission of values such as legality, the fight against corruption, mutual respect, environmental protection, and culture while fostering individual talent – the project Legalità e Merito (Legality and Merit), born from an idea by Luiss Guido Carli’s Vice […]

Read More »

Arbor Metals Completes Comprehensive Spectral Analysis of the Jarnet Lithium Project in James Bay, Quebec

Map Image of Arbor Metals’ Jarnet Lithium Project VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) — Arbor Metals Corp. (“Arbor” or the “Company”) (TSXV: ABR, FWB: 432) announces the successful completion of a detailed spectral analysis of the Jarnet Lithium project located in the James Bay region of Quebec. This comprehensive study marks a […]

Read More »

Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness

PRESS RELEASE Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness New leading gene therapy company created combining late-stage X-linked retinitis pigmentosa (XLRP) program from AGTC, a preclinical program spun out from the University of Oxford and a second preclinical program to […]

Read More »